School of Medicine


Showing 241-252 of 252 Results

  • Arthur Sung, MD, FCCP

    Arthur Sung, MD, FCCP

    Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Sung is a highly esteemed, fellowship-trained interventional pulmonologist and a fellow of the American College of Chest Physicians.

    He is the senior associate chief of the Stanford Medicine Division of Pulmonary, Allergy and Critical Care Medicine. He founded the interventional pulmonology and bronchoscopy for Stanford Medicine in 2013. With Stanford University School of Medicine, he is a clinical associate professor of medicine – pulmonary, allergy and critical care medicine.

    In his clinical practice, Dr. Sung delivers care at Stanford Medicine sites in both Palo Alto, Emeryville and Livermore. He is a recognized expert in the diagnosis and treatment of conditions involving the chest and lungs, including complex airway diseases.

    Patients praise the quality of his care and excellent listening skills. They highlight his ability to answer questions and to explain medical conditions and treatment options clearly and compassionately.

    To advance the field of pulmonology, Dr. Sung is conducting research in airways diseases. He is a principal investigator of a study of variables in computed tomography imaging used to support diagnostic and treatment approaches. He previously served as the site principal investigator for lung volume reduction procedure for COPD.

    Dr. Sung has co-authored articles published in the Journal of Thoracic Oncology, Clinical Lung Cancer, Journal of Thoracic Imaging, Chest, and elsewhere. Topics have included innovations in therapy for pneumonitis and robotic surgical treatment of lung tumors.

    He has written chapters for books such as Principles and Practice of Interventional Pulmonology, Examination of the Larynx through the Bronchoscope, and Airway Anatomy for the Bronchoscopist.

    Dr. Sung has made presentations to the American Thoracic Society, American College of Chest Physicians, and American Association of Bronchology and Interventional Pulmonology. Topics have included lung cancer staging in the era of personalized medicine.

    Dr. Sung has earned recognition from the College of Chest Physicians. The Stanford Leadership Program has recognized his achievements. From the Stanford University Bio-X program, he received a grant to study ultrasound-guided lung biopsy procedures. The Bio-X program fosters interdisciplinary collaboration among biomedical and life science researchers, clinicians, engineers, physicists, and computational scientists.

    He is a member of the American Thoracic Society, American College of Chest Physicians, and American Association of Bronchology and Interventional Pulmonology. He has volunteered his time and expertise to deliver health care services to those in need. New Orleans Mayor Ray Nagins honored Dr. Sung for providing care to victims of Hurricane Katrina.

  • Ruey J. Sung

    Ruey J. Sung

    Professor of Medicine (Cardiovascular Medicine), Emeritus

    Current Research and Scholarly InterestsClinical and basic cardiac electrophysiology

  • Samyuktha Suresh

    Samyuktha Suresh

    Postdoctoral Scholar, Oncology

    Current Research and Scholarly Interests- Exploring the crosstalk between DNA repair mechanisms and protein arginine methyltransferases in triple-negative breast cancer
    - Understanding the role of DNA repair enzymes in the context of breast cancer

  • Katherine Sutherland, PA-C

    Katherine Sutherland, PA-C

    Temporary Employee, Medicine - Med/Blood and Marrow Transplantation

    BioKatherine completed her PA degree at Stanford University and worked as a PA in Cutaneous Oncology for 2 years prior to transitioning to Stanford BMT in 2012. Katherine transitioned to part time work in January 2016 and now works on the inpatient service on an as needed basis.

  • David Svec, MD, MBA

    David Svec, MD, MBA

    Clinical Associate Professor, Medicine

    Current Research and Scholarly InterestsHigh Value Care: Leading quality improvement projects / research initiatives

  • Wendy Sue Lewis Swanson

    Wendy Sue Lewis Swanson

    Adjunct Professor, Sean N. Parker Center for Allergy and Asthma Research - Lab

    BioDr. Wendy Sue Swanson is a pediatrician, health communicator, and expert in digital health. She has dedicated her career to expanding the practice of general pediatrics in part by using public communication tools and digital software to improve education, connection between patients and care teams, and public health. Dr. Swanson started the first physician-authored blog for a major US hospital in 2009 working to combat misinformation in the news and online for families. She was a pioneer in using social media in medicine with a focus on increasing trust in the science and safety of immunizations. For more than a decade, she generated worldwide interest in pediatric public health topics, her team's digital health innovation projects, and prevention solutions by leveraging her blog, social channels, and media opportunities.

    As Chief Medical Officer for a start-up, Dr. Swanson currently leads efforts to foster conversations around the importance of early and consistent inclusion of common allergens in babies' diets. In 2020 she designed an end-to-end, virtual clinical trial enrolling 1500 infants across the US focused on early infant feeding, leveraging EMR-based electronic and online parent chat rooms for novel participant recruitment.

    As a pediatrician, author, and a prominent advocate of evidence-based medicine and prevention, Dr. Swanson speaks internationally on prevention, digital health, and health innovation. She has been a leading voice in health care and media, working to revolutionize health communications by using social and digital media to bridge the gap between parents and doctors.

    Prior to her work at Stanford, Dr Swanson practiced primary care pediatrics for 12 years, worked for the NBC Seattle-affiliate, KING5 News, as a weekly on-air TV medical contributor, and wrote the Seattle Mama Doc blog for Seattle Children’s Hospital for 10 years. Swanson established and founded the Digital Health department in 2013 for the hospital and was later named Chief of Digital Innovation. In that role, Swanson led a team in innovation by testing and creating new digital tools (software, voice technology, social media, outside innovation pilots) and innovation projects across Seattle Children's and the US.

    She is an official spokesperson for The American Academy of Pediatrics and a frequent contributor to national TV, radio, and online news outlets. Her first book, Mama Doc Medicine: Finding Calm and Confidence in Parenting, Child Health, and Work-Life Balance was published by the American Academy of Pediatrics in March, 2014 and is a Gold Award Recipient of the Mom’s Choice Awards.

    Swanson was born and raised in Minnesota. An honors graduate in Psychology from Kenyon College, Dr. Swanson earned an MD and MBE (Master's in Bioethics) at the University of Pennsylvania Perelman School Of Medicine and completed her residency at Seattle Children’s Hospital. Dr. Swanson spent 2 years teaching middle school, bilingual, science & math in Oakland, California through Teach For America before beginning her career in medicine.

    Career Focus: building solutions in prevention, health translation/education, and innovation via the design and development of novel and digital tools that 1) empower patients 2) help healthcare providers perform their jobs at the highest level 3) strengthen communication between these two groups and 4) prevent disease.

  • Andrew Sweatt

    Andrew Sweatt

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Current Research and Scholarly InterestsAiming to advance understanding and treatment of pulmonary arterial hypertension (PAH), Dr. Sweatt's research leverages high-throughput molecular profiling, deep clinical phenotypic data, and data science (machine learning and network-based analysis) to identify novel sub-phenotypes and therapeutically-relevant biomarkers in PAH.